Insider Selling Swells at Arteris – What It Means for Investors
Arteris Inc. saw a sharp spike in insider activity on July 6, 2026, when President and CEO Janac K. Charles sold a total of 5,316 shares under a 10(b)(5)(1) trading plan, and his trust sold 29,490 shares. Combined, the CEO’s plan moved roughly 34,806 shares that day—about 1.5 % of the company’s outstanding equity. The sale price of $35.12 per share is modestly above the market close of $31.32, yet the volume is significant against a backdrop of a 21 % weekly slide and a 273 % yearly gain.
Why the Move Matters
Insider selling is often viewed skeptically, but the context matters. Charles has been disciplined in his use of trading plans, which are typically set up when the executive believes the company’s prospects are stable or improving. The recent series of sales—including the July 6 plan and a prior July 1 block sale—suggest that the CEO is trimming positions, likely to diversify his personal portfolio rather than signal a loss of confidence. The timing coincides with a broader pattern: other officers (e.g., VP Paul Alpern and CFO Nicholas Hawkins) also executed sells around the same week, and Bayview Legacy, a related trust, sold a large block on the same day. Such coordinated selling can be interpreted as a normal liquidity event rather than a red flag.
Implications for Shareholders
For investors, the key takeaway is that the current insider sales do not appear to be a harbinger of imminent corporate trouble. The company’s fundamentals—particularly its high 52‑week high of $50.26 and its continued growth in revenue from network‑on‑chip IP—indicate that Arteris remains on a trajectory of expanding market share. The price‑earnings ratio of –52.96 reflects a negative earnings environment common in high‑growth tech firms, but the stock’s strong yearly performance (273 %) underscores a bullish long‑term narrative. In short, a brief wave of insider liquidity is unlikely to derail the company’s strategic initiatives or its ability to fund R&D.
Profile of Janac K. Charles
Charles has maintained a consistent selling pattern over the past year. From March to July 2026, he executed over 400 transactions, selling roughly 250,000 shares on average per month, often at prices 2–5 % above the market close. His holdings, however, remain substantial—around 8.5 million shares (over 5 % of shares outstanding). The CEO’s use of 10(b)(5)(1) plans, coupled with the regularity of sales, suggests a long‑term view: he is managing risk and securing personal liquidity while keeping a sizable stake that aligns his interests with shareholders. Historically, CEO insiders with such disciplined patterns tend to be engaged in the company’s long‑term success rather than short‑term speculation.
Looking Forward
Arteris is navigating a competitive semiconductor landscape, and its recent insider activity signals routine portfolio management rather than strategic warning. Investors should focus on the company’s pipeline of IP products for automotive and mobile processors, and on its ability to capture market share in high‑performance networking. While short‑term volatility may persist, the insider trend—coupled with strong fundamentals—suggests that Arteris is poised for continued growth.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-07-06 | JANAC K CHARLES (President and CEO) | Sell | 5,316.00 | 35.12 | Common Stock |
| 2026-07-06 | JANAC K CHARLES (President and CEO) | Sell | 2,455.00 | 36.17 | Common Stock |
| 2026-07-06 | JANAC K CHARLES (President and CEO) | Sell | 2,908.00 | 37.12 | Common Stock |
| 2026-07-06 | JANAC K CHARLES (President and CEO) | Sell | 29,490.00 | 37.07 | Common Stock |
| 2026-07-06 | JANAC K CHARLES (President and CEO) | Sell | 27,908.00 | 36.24 | Common Stock |
| 2026-07-06 | JANAC K CHARLES (President and CEO) | Sell | 68,578.00 | 35.07 | Common Stock |
| N/A | JANAC K CHARLES (President and CEO) | Holding | 56,252.00 | N/A | Common Stock |
| 2026-07-06 | Alpern Paul L (VP and General Counsel) | Sell | 1,824.00 | 37.13 | Common Stock |
| 2026-07-06 | Alpern Paul L (VP and General Counsel) | Sell | 1,301.00 | 35.98 | Common Stock |
| 2026-07-06 | Alpern Paul L (VP and General Counsel) | Sell | 2,878.00 | 35.11 | Common Stock |
| 2026-07-06 | Bayview Legacy, LLC () | Sell | 29,490.00 | 37.07 | Common Stock |
| 2026-07-06 | Bayview Legacy, LLC () | Sell | 27,908.00 | 36.24 | Common Stock |
| 2026-07-06 | Bayview Legacy, LLC () | Sell | 68,578.00 | 35.07 | Common Stock |




